Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders
US8586564B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 17, 2009 |
| Grant date | Nov 19, 2013 |
| Priority date | — |
| Expiry date | Dec 8, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes compositions and methods for synthetic analogues and derivatives of β-glycolipids. These analogues and derivatives may be used for the treatment, amelioration or prevention of a pathological disorder. They may also be used for the modulation of the Th1/Th2 cell balance toward an anti-inflammatory or pro-inflammatory response, resulting in the treatment, amelioration or prevention of immune-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.